Ospedale: Azienda Policlinico Universitario Bari Trials

Ospedale: Azienda Policlinico Universitario Bari	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Principi, Mariabeatrice

THD-HP, NCT04107194: Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

Recruiting

362

Europe

Pantoprazole 40mg, Pantorc, Amoxicillin 1000 MG, Zimox, Clarithromycin 500mg, Klacid, Metronidazole, Flagyl, Tetracycline 125 MG, Ambramicina, Bismuth Subcitrate, Denol, Rifabutin 150 MG, Mycobutin, Levofloxacin 500mg, Levoxacin

University of Bari

Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain

02/21

04/22

MONET, NCT06709209: AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis

Recruiting

N/A

300

Europe, Japan, RoW

Colonoscopy after bowel cleansing, Intestinal biopsies, blood sampling, Stool, Clinical follow-up

University College Cork, Olympus

Ulcerative Colitis (UC)

09/26

09/27

M, Manisha

NCT04469686 / 2019-003596-19: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Completed

200

Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Twice Daily - Active, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Once Daily - Active, Twice daily placebo suppository administered with Sephure applicator, Twice Daily - Placebo

Cristcot LLC, Cristcot HCA LLC

Ulcerative Proctitis

07/24

09/24

Suriano, Valeria